CloudMD Stock Options

ByAlbert Laurin

Oct 1, 2020 ##acquire, ##aftermarket, ##antworks, ##bayer, ##benchmark, ##berkshirehathaway, ##betweenplays, ##blackrock, ##bridgwater, ##brown, ##btwnplays, ##buffet, ##cloudmd, ##dalio, ##digital, ##doc, ##docrf, ##DR, ##drhamza, ##health, ##jpmorgan, ##market, ##millenials, ##pharmacy, ##premarket, ##prescribeit, ##profit, ##profitly, ##rogers, ##stockhouse, ##stocks, ##stocktwits, ##telehealth, ##trend, ##trending, ##trendingstocks, ##vanguard #aidanlock

CloudMD has granted 525 000 common shares at $2.15 for a term of Five (5) years to directors, officers and a consultant of the company.

CloudMd according to Yahoo Finance as of today has a low bar set at $2.50 an average price at $2.80 and a high of $3.00.

Cannacord Genuity puts it at $2.50.

TipRanks analysts puts it at $2.60.

The companies exposure is starting to grow as you can see in the link below, Stockhouse has also run a story concerning the Stock Options.

https://stockhouse.com/news/press-releases/2020/09/29/cloudmd-grants-stock-options

Founder/CEO/President, Host, Content Creator and Commentary writer for Betweenplays StockMarket Strategies. Lead author for Betweenplays since March 2020. Albert Laurin is the founder of Betweenplays Media, an independent intelligence and media platform established in 2020. His work focuses on long-form analysis and direct, unscripted executive conversations across markets, technology, real estate, and geopolitics. With a background in accounting, management, marketing, and law enforcement, Laurin applies a disciplined, real-world approach to evaluating financial structures, risk, and incentives. Betweenplays conducts non-paid interviews, preserving editorial independence. In parallel with markets, Laurin is a real-estate broker in the Greater Montreal area, applying the same analytical rigor to real-world economic decisions.